Oral tofacitinib effectively treating eruptive and hypertrophic cutaneous lichen planus

JAAD Case Rep. 2023 Apr 26:37:16-20. doi: 10.1016/j.jdcr.2023.04.017. eCollection 2023 Jul.

Authors

Soundos Youssef¹, Lindsey A Bordone²

Affiliations

¹ Postdoctoral Research Fellow, Department of Dermatology, Columbia University Irving Medical Center, New York, New York.
² Department of Dermatology, Columbia University Irving Medical Center, New York, New York.

No abstract available

Keywords: CLP; JAK inhibitor; JAKi; Janus kinase inhibitor; LP; cutaneous lichen planus; lichen planus; oral tofacitinib.

Publication types

Case Reports